Latest Publications

Share:

Nouveaux modèles de convention unique pour la recherche clinique: plus de standardisation, moins de simplification

De nouveaux modèles de convention unique pour la recherche clinique ont été publiés le 5 aout 2024. Ceux-ci mettent à jour les précédents modèles en prenant en compte les nouvelles tendances de la pratique en matière de...more

New French template agreement for clinical trials: more standardization, less simplification

Two updates to the French national clinical trial template agreements (Convention Unique) were published on August 5, 2024. They update the previous templates to take into account evolving practices in clinical trials. In...more

Q2/2024 Life Science Law Update – Key developments for pharma & device companies in EU

The Q2/24 Life Science and Health Care Law Update covers key trends in the EU and Big Five (France, Germany, Italy, Spain, UK) in life sciences regulatory, corporate, compliance, competition, and privacy....more

Panelists discuss European pharmaceutical trends and how to stay ahead of the game - Life Sciences and Health Care Horizons event...

We were pleased to welcome industry leaders to our Life Sciences and Health Care Horizons event in Zurich, where co-head of Hogan Lovells Life Sciences and Health Care sector Jane Summerfield, and partners Melissa K. Bianchi,...more

The use of IVDs as CDx in pharmaceutical clinical trials - Pathways for legacy companion diagnostic IVDs, IVD performance studies,...

The current European legislation for in vitro diagnostic medical devices (IVD) (Regulation 2017/746 or the IVDR) has created challenges not only for IVD manufacturers but also for pharmaceutical companies....more

Nouvelle contrainte à la charge de l’industrie pharmaceutique dans la lutte contre les pénuries de médicaments

Un nouveau dispositif, porté par le projet de loi de financement de la sécurité sociale pour 2024, pourrait aboutir à imposer aux entreprises exploitant un médicament mature d’intérêt thérapeutique majeur qui souhaiterait en...more

New offensive against the pharmaceutical industry in the fight against medicinal product shortages

A new draft measure, included in the Social Security Financing Bill for 2024, aims to require companies operating a mature medicinal product of major therapeutic interest (MITM) that wishes to suspend or cease marketing it,...more

Collaborative research is blurring boundaries between sponsored studies and IIS

Industry is revising its models in clinical development: new collaborative research between the industry and investigators is becoming more important, resulting in an in-between approach between industry sponsored studies and...more

Panelists discuss how European pharmaceutical companies can stay ahead of the game

We were pleased to welcome industry leaders to our Life Sciences and Health Care Horizons event in Zurich, where co-head of Hogan Lovells Life Sciences and Health Care sector Jane Summerfield, and partners Melissa K. Bianchi,...more

The law aimed at improving the framework for French health care centers has finally been published!

The French law n° 2023-378 of 19 May 2023 on the supervision of health care centers has finally been published in the Journal Officiel. The text, which has reached a consensus, was adopted without major changes. This text is...more

6/2/2023  /  France , Healthcare

La loi visant à améliorer l’encadrement des centres de santé enfin publiée !

La loi n° 2023-378 du 19 mai 2023 relative à l’encadrement des centres de santé a enfin été publiée au Journal Officiel. Ce texte qui a fait consensus, a été adopté sans modification majeure par rapport au projet initialement...more

Successful product launches across the EU, UK, and U.S.

We were pleased to welcome industry leaders to our Life Sciences and Health Care Horizons event in Boston for the first time since the pandemic. At the event, Hogan Lovells attorneys Eliza Andonova, Ina Brock, Kristin...more

Regulation of health care centers: a limited reform on the way

A new bill of law has been proposed to improve the regulation of health care centers in France. While limited in scope as currently drafted, the bill contributes to the establishment of a regulatory framework applicable to...more

La réforme de l’encadrement des centres de santé, une réglementation attendue mais dont les contours restent encore limités

Une nouvelle proposition de loi est en cours d’adoption, visant à améliorer l’encadrement des centres de santé en France. Ce texte participe à la construction du cadre réglementaire applicable à la mise en place de ces...more

Dispositif Encadrement des avantages : actualisation de la liste des typologies thématiques des avantages et des conventions

Répondant aux critiques émanant de la pratique, un arrêté en date du 20 janvier 2023 a modifié l'arrêté du 24 septembre 2020 portant sur la typologie thématique des avantages et des conventions en application de l'article...more

French anti-benefits regulation: update of the list of thematic typologies of benefits and agreements

More than two years after the publication of the ministerial order of 24 September 2020 establishing a “thematic typology” of benefits and agreements provided for in Article R1453-14 of the French Public Health Code, a...more

Can sterile drug manufacturers implement EU GMP Annex 1 requirements before August?

In August 2022, the European Commission published a revision to Annex 1 “Manufacture of Sterile Medicinal Products” in EudraLex - Volume 4 - Good Manufacturing Practice (GMP) guidelines that will significantly impact...more

Loi de financement de la sécurité sociale pour 2023 : cadeau de fin d’année pour les sociétés de téléconsultation

La loi du 23 décembre 2022 de financement de la sécurité sociale pour 2023 a entériné l’adoption d’un nouveau régime d’agrément applicable aux sociétés de téléconsultation afin de favoriser la prise en charge des services de...more

Social Security Financing Law for 2023: a year-end gift for teleconsultation companies

The social security financing act for 2023, dated 23 December 2022, has endorsed the adoption of a new accreditation regime applicable to teleconsultation companies to facilitate the reimbursement of the teleconsultation...more

Online gaming regulatory practice in France - Part 1: T&C of video game digital distribution stores

The online gaming sector is characterized by various regulatory frameworks, that may or may not overlap depending on the type of games and means of distribution. There are a number of stakeholders on the value chain...more

Teleconsultations in France: a (r)evolution coming for commercial companies?

Analysis and update on a possible major evolution of the regulation applicable to telemedicine, currently borne by the Social Security Financing Bill for 2023 and being discussed by the French Parliament. The Social Security...more

Téléconsultations : (r)évolution à venir pour les sociétés commerciales ?

Analyse et point d’étape concernant une possible évolution majeure de la règlementation applicable aux actes de télémédecine qui est actuellement portée par le PLFSS 2023 et en cours de discussion devant le Parlement - Le...more

World Stem Cell Summit panel compares global trends in regenerative medicine regulations

Speaking at the World Stem Cell Summit hosted by the Regenerative Medicine Foundation, Hogan Lovells partners Mike Druckman, Ernesto Algaba, Mandi Jacobson, Lu Zhou, Mikael Salmela, Charlotte Damiano, and Lowell Zeta, along...more

France - E-merchants, don’t forget to update your T&Cs of sale!

A new French Decree on the legal guarantee of conformity of goods, digital content and digital services was published on June 30th, 2022. A new French Decree no. 2022-946 on the legal guarantee of conformity of goods, digital...more

France - E-commerçants, n’oubliez pas de mettre à jour vos CGV !

Un nouveau décret relatif à la garantie légale de conformité pour les biens, les contenus numériques et les services numériques a été publié le 30 juin 2022...more

43 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide